1366302-52-4
Chemical Structure
PSMA-11
Synonym(s): HBED-CC-PSMA
- CAS No.: 1366302-52-4
- Formula:C44H62N6O17
- Molecular Weight:946.99
IUPAC Name: (3S,7S)-22-(3-(((2-((5-(2-carboxyethyl)-2-hydroxybenzyl)(carboxymethyl)amino)ethyl)(carboxymethyl)amino)methyl)-4-hydroxyphenyl)-5,13,20-trioxo-4,6,12,19-tetraazadocosane-1,3,7-tricarboxylic acid
InChIKey: QJUIUFGOTBRHKP-LQJZCPKCSA-N
SMILES: OC(CN(CCN(CC(O)=O)CC1=CC(CCC(O)=O)=CC=C1O)CC2=CC(CCC(NCCCCCC(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)=O)=CC=C2O)=O
Biological Activity: PSMA-11 is a small molecule ligand that targets prostate-specific membrane antigen (PSMA) and has the ability to inhibit PSMA activity. PSMA-11 can be used to synthesize 68Ga-PSMA-11, a positron emission tomography (PET) tracer that can be used to image advanced prostate cancer[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PSMA-11 | 99.61% | PSMA-11 is a small molecule ligand that targets prostate-specific membrane antigen (PSMA) and has the ability to inhibit PSMA activity. PSMA-11 can be used to synthesize 68Ga-PSMA-11, a positron emission tomography (PET) tracer that can be used to image advanced prostate cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.58
HY-178248PSMA-R2 -
Similarity Score 0.58
HY-160893PSMA-azide -
Similarity Score 0.57
HY-139670PSMA–DA1 -
Similarity Score 0.56
HY-174808SC691 -
Similarity Score 0.56
HY-153551HBED-CC-tris(tert-butyl ester) -
Similarity Score 0.55
HY-181696EC0652 -
Similarity Score 0.54
HY-P10012Pendetide -
Similarity Score 0.54
HY-148761Zadavotide guraxetan -
Similarity Score 0.54
HY-153130(S)-Zadavotide guraxetan -
Explore the MedChemAI to find more analogs
References
- [1]. Demirci E, et al. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging. Nucl Med Commun. 2016 Nov;37(11):1169-79. [Content Brief]
- [2]. Eder M, et al. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging[J]. Bioconjugate chemistry, 2012, 23(4): 688-697. [Content Brief]
- [3]. Bois F, et al. [68Ga] Ga-PSMA-11 in prostate cancer: a comprehensive review[J]. American Journal of Nuclear Medicine and Molecular Imaging, 2020, 10(6): 349. [Content Brief]
